Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema: the choice of second-line corticosteroid should be left to the clinical judgement of the treating physician”

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Jonas, Jost B. (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 2018
In: Ophthalmologica
Year: 2017, Jahrgang: 239, Heft: 4, Pages: 238-239
ISSN:1423-0267
DOI:10.1159/000481737
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000481737
Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/481737
Volltext
Verfasserangaben:Jost B. Jonas

MARC

LEADER 00000caa a2200000 c 4500
001 1694608018
003 DE-627
005 20220818041756.0
007 cr uuu---uuuuu
008 200415r20182017xx |||||o 00| ||eng c
024 7 |a 10.1159/000481737  |2 doi 
035 |a (DE-627)1694608018 
035 |a (DE-599)KXP1694608018 
035 |a (OCoLC)1341315054 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jonas, Jost B.  |d 1958-  |e VerfasserIn  |0 (DE-588)1028286732  |0 (DE-627)730536823  |0 (DE-576)37578537X  |4 aut 
245 1 0 |a Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema  |b the choice of second-line corticosteroid should be left to the clinical judgement of the treating physician”  |c Jost B. Jonas 
246 3 3 |a ILUVIEN in diabetic macular edema$dthe choice of second-line corticosteroid should be left to the clinical judgement of the treating physician 
264 1 |c 2018 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.04.2020 
500 |a Published online: December 21, 2017 
534 |c 2017 
773 0 8 |i Enthalten in  |t Ophthalmologica  |d Basel : Karger, 1938  |g 239(2018), 4, Seite 238-239  |h Online-Ressource  |w (DE-627)300897391  |w (DE-600)1483531-9  |w (DE-576)276271181  |x 1423-0267  |7 nnas  |a Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema the choice of second-line corticosteroid should be left to the clinical judgement of the treating physician” 
773 1 8 |g volume:239  |g year:2018  |g number:4  |g pages:238-239  |g extent:2  |a Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema the choice of second-line corticosteroid should be left to the clinical judgement of the treating physician” 
856 4 0 |u https://doi.org/10.1159/000481737  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.karger.com/Article/FullText/481737  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200415 
993 |a Editorial 
994 |a 2018 
998 |g 1028286732  |a Jonas, Jost B.  |m 1028286732:Jonas, Jost B.  |d 60000  |e 60000PJ1028286732  |k 0/60000/  |p 1  |x j  |y j 
999 |a KXP-PPN1694608018  |e 3623925241 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"2 S."}],"name":{"displayForm":["Jost B. Jonas"]},"relHost":[{"part":{"volume":"239","extent":"2","year":"2018","pages":"238-239","text":"239(2018), 4, Seite 238-239","issue":"4"},"language":["ger"],"corporate":[{"display":"Nederlands Oogheelkundig Gezelschap","role":"isb"}],"id":{"issn":["1423-0267"],"zdb":["1483531-9"],"eki":["300897391"]},"recId":"300897391","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema the choice of second-line corticosteroid should be left to the clinical judgement of the treating physician”Ophthalmologica","note":["Gesehen am 30.06.25"],"pubHistory":["96.1938/39 -"],"origin":[{"publisherPlace":"Basel","dateIssuedDisp":"1938-","publisher":"Karger","dateIssuedKey":"1938"}],"title":[{"title":"Ophthalmologica","title_sort":"Ophthalmologica","subtitle":"international journal of ophthalmology ; journal international d'ophtalmologie ; internationale Zeitschrift für Augenheilkunde ; organ of the Netherlands Ophthalmological Society"}]}],"recId":"1694608018","id":{"doi":["10.1159/000481737"],"eki":["1694608018"]},"title":[{"title_sort":"Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema","subtitle":"the choice of second-line corticosteroid should be left to the clinical judgement of the treating physician”","title":"Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema"}],"note":["Gesehen am 15.04.2020","Published online: December 21, 2017"],"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"titleAlt":[{"title":"ILUVIEN in diabetic macular edema$dthe choice of second-line corticosteroid should be left to the clinical judgement of the treating physician"}],"person":[{"display":"Jonas, Jost B.","family":"Jonas","role":"aut","given":"Jost B."}]} 
SRT |a JONASJOSTBREPLYTOTHE2018